Edition:
India

Karo Pharma AB (KARO.ST)

KARO.ST on Stockholm Stock Exchange

29.20SEK
5:18pm IST
Change (% chg)

-0.65kr (-2.18%)
Prev Close
29.85kr
Open
29.65kr
Day's High
29.70kr
Day's Low
29.10kr
Volume
592,707
Avg. Vol
542,875
52-wk High
41.68kr
52-wk Low
25.25kr

Select another date:

Mon, Apr 30 2018

BRIEF-Karo Pharma Determines Terms For Rights Issue

* THE TERMS FOR KARO PHARMA'S RIGHTS ISSUE HAVE BEEN DETERMINED

BRIEF-Karo Pharma Q1 EBITDA rose to SEK 89 mln

* KARO PHARMA DOUBLES SALES AND EARNINGS IN THE FIRST QUARTER

BRIEF-Karo Pharma: Board Of Directors Resolves On Fully Guaranteed Rights Issue

* THE BOARD OF DIRECTORS OF KARO PHARMA HAS RESOLVED ON A FULLY GUARANTEED RIGHTS ISSUE SUBJECT TO APPROVAL BY THE ANNUAL GENERAL MEETING

BRIEF-Karo Pharma Intends To Propose Dividend Of SEK 0.30 Per Share

* INTENDS TO PROPOSE DIVIDEND OF SEK 0.30 PER SHARE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Karo Pharma Acquires Major Product Portfolio for EUR 260 Mln

* ‍ACQUIRES A PRODUCT PORTFOLIO FROM DANISH PHARMACEUTICAL COMPANY LEO PHARMA A/S FOR 260 MEURO​

BRIEF-Karo Pharma AB Q4 Adjusted EBITDA Rises To SEK 41.8 Mln

* Q4 NET SALES SEK 238.7 MILLION VERSUS SEK 96.5 MILLION YEAR AGO

BRIEF-Karo Pharma Says RORgamma Project Is Not Shut Down

* SAYS RORGAMMA PROJECT IS NOT SHUT DOWN BUT CARRIES ON AS PLANNED Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Karo Pharma Rights Issue Subscribed To 170 Percent

* RIGHTS ISSUE SUBSCRIBED TO 170 PERCENT WITH PROCEEDS AT ABOUT SEK 794.3 MILLION BEFORE ISSUE COSTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Select another date: